chr2-175179201-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001689.5(ATP5MC3):āc.170A>Gā(p.Gln57Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001689.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP5MC3 | NM_001689.5 | c.170A>G | p.Gln57Arg | missense_variant | 4/5 | ENST00000284727.9 | NP_001680.1 | |
ATP5MC3 | NM_001002258.5 | c.170A>G | p.Gln57Arg | missense_variant | 3/4 | NP_001002258.1 | ||
ATP5MC3 | NM_001190329.2 | c.170A>G | p.Gln57Arg | missense_variant | 4/4 | NP_001177258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP5MC3 | ENST00000284727.9 | c.170A>G | p.Gln57Arg | missense_variant | 4/5 | 1 | NM_001689.5 | ENSP00000284727.4 | ||
ATP5MC3 | ENST00000392541.3 | c.170A>G | p.Gln57Arg | missense_variant | 3/4 | 1 | ENSP00000376324.3 | |||
ATP5MC3 | ENST00000409194.5 | c.170A>G | p.Gln57Arg | missense_variant | 4/5 | 2 | ENSP00000387317.1 | |||
ATP5MC3 | ENST00000497075.5 | n.298A>G | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461882Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727240
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at